BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30961539)

  • 1. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Pu K; Wang Y; Bai S; Wei H; Zhou Y; Fan J; Qiao L
    BMC Gastroenterol; 2019 Apr; 19(1):51. PubMed ID: 30961539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
    Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
    United European Gastroenterol J; 2020 Apr; 8(3):321-331. PubMed ID: 32213023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases.
    Ni XX; Lian M; Wu HM; Li XY; Sheng L; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Hua J
    World J Gastroenterol; 2021 Jan; 27(1):80-91. PubMed ID: 33505152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease].
    Goncharov AA; Sasunova AN; Pilipenko VI; Isakov VA
    Ter Arkh; 2023 Oct; 95(8):641-647. PubMed ID: 38158897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
    Runge JH; van Giessen J; Draijer LG; Deurloo EE; Smets AMJB; Benninga MA; Koot BGP; Stoker J
    Eur Radiol; 2021 Mar; 31(3):1588-1596. PubMed ID: 32910234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
    Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R
    Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis.
    Cai C; Song X; Chen X; Zhou W; Jin Q; Chen S; Ji F
    Can J Gastroenterol Hepatol; 2021; 2021():8859338. PubMed ID: 33542909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled attenuation parameter accurately detects liver steatosis in people with HIV.
    Duarte M; Tien P; Ma Y; Noworolski SM; Korn N; Price JC
    AIDS; 2022 Dec; 36(15):2147-2152. PubMed ID: 35950941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.
    Steinmann S; Hartl J; Weidemann S; Füssel K; Kroll C; Sebode M; Lohse AW; Schramm C
    JHEP Rep; 2023 Dec; 5(12):100898. PubMed ID: 37954487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
    Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
    Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
    Bangaru S; Sundaresh R; Lee A; Prause N; Hao F; Dong TS; Tincopa M; Cholankeril G; Rich NE; Kawamoto J; Bhattacharya D; Han SB; Patel AA; Shaheen M; Benhammou JN
    Dig Dis Sci; 2023 Dec; 68(12):4474-4484. PubMed ID: 37864738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Shen Q; Hao Y; Chen J; Liu Q; Jia H; Liu L
    Curr Med Imaging; 2024; 20():1-12. PubMed ID: 38389362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter.
    Mak LY; Chan AC; Wong TC; Dai WC; She WH; Ma KW; Sin SL; Chu KW; Seto WK; Yuen MF; Lo CM; Fung J
    BMC Gastroenterol; 2023 Sep; 23(1):307. PubMed ID: 37700227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical research of fibroscan ‒ TE-CAP at noninvasive diagnosis of hepatic steatosis in children.
    Jia S; Zhou J; Zhang Q; Zhou S; Wang Z; Ye X; Wu J
    Clinics (Sao Paulo); 2024; 79():100387. PubMed ID: 38805982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity.
    Peng T; Yi X; Lin Y; Dong X; Zhang P; Qiao Z; Li L
    J Pediatr Endocrinol Metab; 2024 May; ():. PubMed ID: 38723170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Score Based on Controlled Attenuation Parameter Accurately Predicts Hepatic Steatosis in Individuals With Metabolic Dysfunction Associated Steatotic Liver Disease: A Derivation and Independent Validation Study.
    An ZM; Liu QH; Ye XJ; Zhang Q; Pei HF; Xin X; Yuan J; Huang Q; Liu K; Lu F; Yan ZH; Zhao Y; Hu YY; Zheng MH; Feng Q
    Clin Transl Gastroenterol; 2024 Mar; 15(3):e00680. PubMed ID: 38240390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Obesity-Related Indicators for Nonalcoholic Fatty Liver Disease Diagnosed by Transient Elastography.
    Tian X; Ding N; Su Y; Qin J
    Turk J Gastroenterol; 2023 Oct; 34(10):1078-1087. PubMed ID: 37737216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population.
    Yang Y; Liu J; Sun C; Shi Y; Hsing JC; Kamya A; Keller CA; Antil N; Rubin D; Wang H; Ying H; Zhao X; Wu YH; Nguyen M; Lu Y; Yang F; Huang P; Hsing AW; Wu J; Zhu S
    Eur Radiol; 2023 Aug; 33(8):5894-5906. PubMed ID: 36892645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-hour post-load glucose levels are associated with hepatic steatosis assessed by transient elastography.
    Andreozzi F; Mancuso E; Mazza E; Mannino GC; Fiorentino TV; Arturi F; Succurro E; Perticone M; Sciacqua A; Montalcini T; Pujia A; Sesti G
    Diabetes Obes Metab; 2024 Feb; 26(2):682-689. PubMed ID: 37953652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
    Vianna P; Calce SI; Boustros P; Larocque-Rigney C; Patry-Beaudoin L; Luo YH; Aslan E; Marinos J; Alamri TM; Vu KN; Murphy-Lavallée J; Billiard JS; Montagnon E; Li H; Kadoury S; Nguyen BN; Gauthier S; Therien B; Rish I; Belilovsky E; Wolf G; Chassé M; Cloutier G; Tang A
    Radiology; 2023 Oct; 309(1):e230659. PubMed ID: 37787678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.